Patents by Inventor Paul Waring

Paul Waring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220051804
    Abstract: Heterogeneity for biomarkers in a tissue sample can be calculated. A heterogeneity score can be combined with an immunohistochemistry combination score to provide breast cancer recurrence prognosis. Heterogeneity can be based on percent positivity determinations for a plurality of biomarkers according to how many cells in the sample stain positive. An immunohistochemistry combination score can be calculated. An imaging tool can support a digital pathologist workflow that includes designating fields of view in an image of the tissue sample. Based on the fields of view, a heterogeneity metric can be calculated and combined with an immunohistochemistry combination score to generate a breast cancer recurrence prognosis score.
    Type: Application
    Filed: October 28, 2021
    Publication date: February 17, 2022
    Inventors: Srinivas Chukka, Olcay Sertel, Anindya Sarkar, Nikolaus Wick, Shalini Singh, Crystal Schemp, Paul Waring, Raymond Tubbs
  • Patent number: 11211167
    Abstract: Heterogeneity for biomarkers in a tissue sample can be calculated. A heterogeneity score can be combined with an immunohistochemistry combination score to provide breast cancer recurrence prognosis. Heterogeneity can be based on percent positivity determinations for a plurality of biomarkers according to how many cells in the sample stain positive. An immunohistochemistry combination score can be calculated. An imaging tool can support a digital pathologist workflow that includes designating fields of view in an image of the tissue sample. Based on the fields of view, a heterogeneity metric can be calculated and combined with an immunohistochemistry combination score to generate a breast cancer recurrence prognosis score.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: December 28, 2021
    Assignees: VENTANA MEDICAL SYSTEMS, INC., THE CLEVELAND CLINIC FOUNDATION, THE UNIVERSITY OF MELBOURNE
    Inventors: Srinivas Chukka, Olcay Sertel, Anindya Sarkar, Nikolaus Wick, Shalini Singh, Crystal Schemp, Paul Waring, Raymond Tubbs
  • Publication number: 20150347702
    Abstract: Heterogeneity for biomarkers in a tissue sample can be calculated. A heterogeneity score can be combined with an immunohistochemistry combination score to provide breast cancer recurrence prognosis. Heterogeneity can be based on percent positivity determinations for a plurality of biomarkers according to how many cells in the sample stain positive. An immunohistochemistry combination score can be calculated. An imaging tool can support a digital pathologist workflow that includes designating fields of view in an image of the tissue sample. Based on the fields of view, a heterogeneity metric can be calculated and combined with an immunohistochemistry combination score to generate a breast cancer recurrence prognosis score.
    Type: Application
    Filed: December 19, 2013
    Publication date: December 3, 2015
    Inventors: Srinivas Chukka, Olcay Sertel, Anindya Sarkar, Nikolaus Wick, Shalini Singh, Crystal Schemp, Paul Waring, Raymond Tubbs
  • Patent number: D806022
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: December 26, 2017
    Inventor: John Paul Waring